|4May 18, 8:42 PM ET

Burkhart Erin 4

4 · BIOMARIN PHARMACEUTICAL INC · Filed May 18, 2022

Insider Transaction Report

Form 4
Period: 2022-05-16
Burkhart Erin
GVP, Chief Accounting Officer
Transactions
  • Award

    Common Stock

    2022-05-16+11,13011,130 total
  • Award

    Stock Option (Right to buy Common Stock)

    2022-05-16+17,49017,490 total
    Exercise: $77.32From: 2023-05-16Exp: 2032-05-15Common Stock (17,490 underlying)
Footnotes (2)
  • [F1]Restricted stock units granted on May 16, 2022. Price not applicable.
  • [F2]Option grant vests 12/48th on May 16, 2023 and 1/48th on the 16th day of each month thereafter.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4